Temporary injection-site pain, redness, warmth, nausea, dizziness, headache, or rash may occur
The differences between the individual values of GSH content of liver determined in this assay were small, thus, confirming the literature report that GSH content of liver did not change when an animal was pretreated with microsomal drug-metabolizing inducers such as phenobarbitone, 3-methylcholanthrene and polychlorinated biphenyl (Arcolor 1254)
Research background matters because peptide handling, sequence stability, and route-specific formulation all affect interpretation
4.1.2 Autism Spectrum disorders Surprisingly, there are few studies looking at sulforaphanes effectiveness in autism preclinical models considering most of the clinical trials (discussed later) for sulforaphane in neurological conditions focused on the ASD patient pool